ClinicalTrials.gg
Sign In
RecruitingNCT07840209Updated Sep 24, 2026

Comparison of Hand Eye Coordination and Sports Vision Performance in Dual-Focus Multifocal Contact Lenses and Habitual Contact Lenses

An interventional study of Multifocal Contact Lens in Myopia, sponsored by Ohio State University. Recruiting at 1 site in United States. Open to participants aged 18 Years to 38 Years. Per ClinicalTrials.gov, last updated 2026-09-24.

Sponsored by Ohio State University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 38 Years
Sex
All
01

Study summary

The purpose of the study is to compare the hand-eye coordination and sports vision performance in participants while they are wearing their habitual contact lenses versus while wearing the dual-focus multifocal contact lenses.

02

Conditions studied

  • Myopia

Browse trials for

Keywords

  • Sports vision
  • contact lenses
03

In context

Myopia

1,159 studies on the registry are indexed under Myopia; 225 are open to participants now.

This study's planned enrollment of 20 is below the median of 78 across 923 interventional studies indexed under Myopia.

Browse Myopia studies →

Lead sponsor

Ohio State University is the lead sponsor of 663 studies on the registry; 148 are open to participants now.

Of its 67 completed or terminated interventional studies of FDA-regulated products, 49 (73%) have results posted.

Browse Ohio State University studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 38 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Adult, aged 18 to 38 with baseball or softball playing experience (high school or higher in the last 10 years)
  2. Ability to give
  3. Good general health defined by medication use that has not changed within the last 30 days and the absence of medical conditions or treatments that are deemed confounding to the data as determined by the Investigator
  4. Current myopic spherical soft contact lens wearer with a prescription equivalent to the multifocal lens powers available
  5. Visual acuity of 20/25 or better in each eye with current soft contact lenses
  6. Visual acuity of 20/25 or better in each eye in multifocal contact lenses
  7. Stereoacuity of 40" or better at 40 cm
  8. Willing to spend time required for attending 3 study visits and wearing contact lenses on days between study visits
  9. Any gender
  10. Any racial or ethnic origin

Exclusion criteria

Exclusion Criteria:

  1. Current or active inflammation, infection, or eye disease as determined by the Investigator
  2. A systemic condition that in the opinion of the investigator may affect a study outcome
  3. Strabismus
  4. Unable to successfully wear the MiSight contact lenses for the duration of the study
  5. Females who are pregnant, lactating, or planning to conceive during the study
  6. Use of systemic or topical medication that in the opinion of the investigator may affect a study outcome variable
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Habitual contact lenses worn first, multifocal lenses worn second

    Participants will wear their habitual contact lenses while completing tasks first, then wear the provided multifocal lenses while completing tasks again.

    Device: Multifocal Contact Lens

  • Experimental
    Multifocal lenses worn first, habitual lenses worn second.

    Participants will wear the multifocal lenses while completing tasks first, then wear their habitual lenses while completing tasks again.

    Device: Multifocal Contact Lens

Interventions

  • DeviceMultifocal Contact Lens

    Multifocal Contact Lens

06

What researchers measure

Primary outcomes

  1. Hand-eye coordination and sport vision performance

    The average score of the AcuVision while wearing the multifocal contact lenses compared to the score when wearing their habitual contact lenses.

    Time frame: 3 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Dec 2027, 14 months later.

Of 200 non-industry interventional studies with no phase under Myopia, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 14 months is below that.

Counting every sponsor, half of 434 studies reached it within 14 months; a quarter within 3 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 16, 2026
First posted
Sep 24, 2026
StartEst.
Oct 2026
Primary completionEst.
Dec 2027
CompletionEst.
Dec 2027
Last update
Sep 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07840209
Lead sponsor
Ohio State University
Responsible party
Jennifer Fogt (Assistant Professor, Ohio State University) — Principal investigator
First posted
Sep 24, 2026
Start date
Oct 2026 (estimated)
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Sep 24, 2026

Study contacts

iVERG Reserch Group
Contact
OPT-EyeStudies@osu.edu
614-292-8858

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Myopia →

Other studies from this sponsor

Ohio State University →

Start the discussion